 |
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America |
 |
FDA Extends PDUFA Action Date for STEDESA™ New Drug Application |
 |
Dainippon Sumitomo Pharma America Announces the NDA Submission of Lurasidone to the FDA for the Treatment of Schizophrenia |
 |
Sepracor Granted Patent Term Extension for LUNESTA® and Provides Update on LUNESTA Pediatric Studies |